Britain's Most Admired Companies 2012: Health & Household

This is a Most Admired debut for the Health & Household sector. The pharmaceuticals industry is big business and these players, selling everything from aspirin to snakebite antidote, have the formula for success.

by MT Staff
Last Updated: 11 Nov 2013

GlaxoSmithKline, maker of everything from Ribena to cancer treatments, tops the sector. Despite falling sales, the drugs giant is increasing its dividend, and CEO Andrew Witty is restructuring the business to give more weight to emerging markets. It was recently fined a record $3bn (£1.9bn) for mis-selling drugs in the US. At number two, Pfizer faces serious challenges from cut-price rivals and the patent cliff – US protection for its cholesterol buster Lipitor expired last year and sales nosedived 71%. Artificial joint specialist Smith & Nephew, hit by health service cost-cutting, is looking to sports medicine to boost margins. BTG, which produces a snakebite antidote among other things, made £18.3m half-year profits.

Go to the BMAC homepage

BMAC 2012 by sector: Health & Household

Ranking Name Score
1. GlaxoSmithKline 66.2
2. Pfizer (UK) 65.5
3. Smith & Nephew 60.0
4. BTG 59.1
5. Shire 57.7

Find this article useful?

Get more great articles like this in your inbox every lunchtime

How to use workplace conflict to your advantage

But beware the festering feud.

Efficient chickens, less stuff, more optimism: The real way to address climate change ...

What is dematerialisation, and why does it matter?

The 5 behaviours of charismatic leaders

How to become more inspirational (without having a personality transplant).

When should you step down as CEO?

Bob Iger's departure poses an unpopular question for bosses.

The death and resurrection of the premium customer

Top-end service is no longer at the discretion of the management.

What HS2 can teach you about project failure

And how you can prevent projects going astray.